Case Report: Successful treatment of pyoderma gangrenosum-like granulomatous liver disease without skin lesions using a TNF-alpha inhibitor - Takeaways - MDSpire

Case Report: Successful treatment of pyoderma gangrenosum-like granulomatous liver disease without skin lesions using a TNF-alpha inhibitor

  • By

  • Isabelle Panne

  • Matthias Matter

  • Jürg Vosbeck

  • Matthias von Rotz

  • Alexandra Steinemann

  • Marten Trendelenburg

  • Markus H. Heim

  • Peter Schirmacher

  • Andrea De Gottardi

  • Ansgar W. Lohse

  • Luigi M. Terracciano

  • Christine Bernsmeier

  • June 15, 2026

  • 0 min

Share

  • 1

    A 73-year-old man presented with isolated hepatic and ocular involvement of pyoderma gangrenosum without skin lesions, highlighting diagnostic challenges.

  • 2

    The patient exhibited elevated liver enzymes and CRP, alongside imaging revealing disseminated nodular liver lesions and histological findings of granulomatous inflammation.

  • 3

    Extensive testing excluded common infectious, malignant, and autoimmune causes, reinforcing the rarity of hepatic involvement in pyoderma gangrenosum.

  • 4

    Immunosuppressive treatment with prednisone followed by infliximab led to complete clinical and biochemical remission in the patient.

  • 5

    This case emphasizes the systemic nature of pyoderma gangrenosum and the need for awareness of extracutaneous manifestations in clinical practice.

Original Source(s)

Related Content